Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.
Parainfluenza virus (PIV) infection can be a problem among hematopoetic stem cell transplant recipients. 125 patients were prospectively evaluated for respiratory viral infections. We describe 5 patients with PIV 3 infection and their response to early treatment with ribavirin.
Chakrabarti
S
S
Department of Haematology, Birmingham Heartlands Hospital, Birmingham, United Kingdom.
Collingham
K E
KE
Holder
K
K
Oyaide
S
S
Pillay
D
D
Milligan
D W
DW
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010224:Parainfluenza Virus 3, Human; D011446:Prospective Studies; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000821:virology; D010253:Respirovirus Infections / Q000188:drug therapy* / Q000821:virology; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome
D000998:Antiviral Agents; D012254:Ribavirin